TGFB1 and diabetic kidney disease: Pirfenidone, a small molecule inhibitor of TGF-β signaling, improved GFR in a small study of focal segmental glomerulonephritis patients [163] as well as in a randomized double-blind placebo-controlled study in patients with diabetic nephropathy [163].